Back to top

Repligen (RGEN) Receives a Buy from Craig-Hallum

In a report released on September 19, Matt Hewitt from Craig-Hallum reiterated a Buy rating on Repligen, with a price target of $204.00. The compan...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Repligen Corporation (RGEN)